Molecular classification of non-small-cell lung cancer: diagnosis, individualized treatment, and prognosis (Q38107464)

29 August 2017

title

Molecular classification of non-small-cell lung cancer: diagnosis, individualized treatment, and prognosis (English)

1 reference

29 August 2017

1 reference

1 reference

Yue Yu

1

1 reference

29 August 2017

Jie He

series ordinal

2

1 reference

29 August 2017

publication date

17 May 2013

1 reference

29 August 2017

published in

Frontiers of medicine

1 reference

29 August 2017

volume

7

1 reference

29 August 2017

issue

2

1 reference

29 August 2017

page(s)

157-171

1 reference

Emerging new agents for the management of patients with non-small cell lung cancer

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Gene expression profiling of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

IASLC/ATS/ERS International Multidisciplinary Classification of Lung Adenocarcinoma: novel concepts and radiologic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Genetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis: its association with clinicopathologic features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Clinical and molecular analysis of synchronous double lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Use of epidermal growth factor receptor/Kirsten rat sarcoma 2 viral oncogene homolog mutation testing to define clonal relationships among multiple lung adenocarcinomas: comparison with clinical guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Diversity of gene expression in adenocarcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Classification of lung cancer tumors based on structural and physicochemical properties of proteins by bioinformatics models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Prognostic significance of micrometastasis in non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Prediction of lymph node metastasis by analysis of gene expression profiles in primary lung adenocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Prediction of lymph node metastasis by analysis of gene expression profiles in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Personalized targeted therapy for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Accumulation of driver and passenger mutations during tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Molecular profiling to optimize treatment in non-small cell lung cancer: a review of potential molecular targets for radiation therapy by the translational research program of the radiation therapy oncology group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

A novel classification of lung cancer into molecular subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Epidermal growth factor receptor tyrosine kinase defines critical prognostic genes of stage I lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Genetic testing for lung cancer: reflex versus clinical selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Hybrid Models Identified a 12-Gene Signature for Lung Cancer Prognosis and Chemoresponse Prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Prognostic and predictive value of a malignancy-risk gene signature in early-stage non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

The BATTLE trial: personalizing therapy for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Expression profiling-based subtyping identifies novel non-small cell lung cancer subgroups and implicates putative resistance to pemetrexed therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Prediction of radiation sensitivity using a gene expression classifier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Systems biology modeling of the radiation sensitivity network: a biomarker discovery platform.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

The effect of surgical treatment on survival from early lung cancer. Implications for screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Gene-expression signature predicts postoperative recurrence in stage I non-small cell lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Constructing molecular classifiers for the accurate prognosis of lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

A gene expression signature predicts survival of patients with stage I non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Non-overlapping and non-cell-type-specific gene expression signatures predict lung cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

A five-gene signature and clinical outcome in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Robust gene expression signature from formalin-fixed paraffin-embedded samples predicts prognosis of non-small-cell lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

21 January 2018

Epigenetics in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Cancer genetics and epigenetics: two sides of the same coin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Gene-promoter hypermethylation as a biomarker in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Integrated analysis of genetic and epigenetic alterations reveals CpG island methylator phenotype associated with distinct clinical characters of lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Cytosine methylation profiles as a molecular marker in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

MicroRNAs accurately identify cancer tissue origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

MicroRNA expression differentiates histology and predicts survival of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

miR-205 Expression levels in nonsmall cell lung cancer do not always distinguish adenocarcinomas from squamous cell carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Proteomics analysis in lung cancer: challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

A 6-antibody panel for the classification of lung adenocarcinoma versus squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

The changing epidemiology of lung cancer in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Squamous cell carcinoma of the lung: molecular subtypes and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Comprehensive genomic characterization of squamous cell lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

A computational index derived from whole-genome copy number analysis is a novel tool for prognosis in early stage lung squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

The transcriptional landscape and mutational profile of lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

KIF5B-RET fusions in lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Genomic landscape of non-small cell lung cancer in smokers and never-smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Anticipating the 1,000 dollar genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

The $1,000 genome, the $100,000 analysis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Treatment of ALK-positive non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Molecular classification of nonsmall cell lung cancer using a 4-protein quantitative assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Three-Gene Prognostic Classifier for Early-Stage Non–Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0272-4

Study of the diagnostic difference between the clinical diagnostic criteria and results of immunohistochemical staining of multiple primary lung cancers

21 January 2018

1 reference

12 December 2020

Gene Expression Signature Predicts Recurrence in Lung Adenocarcinoma

1 reference

12 December 2020

Use of MicroRNA Expression Levels to Predict Outcomes in Resected Stage I Non-small Cell Lung Cancer

1 reference

12 December 2020

Interobserver variability in histopathologic subtyping and grading of pulmonary adenocarcinoma

1 reference

12 December 2020

Gene-expression profiles predict survival of patients with lung adenocarcinoma

1 reference

12 December 2020

An immune response enriched 72-gene prognostic profile for early-stage non-small-cell lung cancer

1 reference

12 December 2020

A new method for lung cancer prognosis via centrosome image feature analysis

1 reference

12 December 2020

Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung

1 reference

12 December 2020

Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma

1 reference

12 December 2020

Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas

1 reference

12 December 2020

Cancer genomics: from discovery science to personalized medicine

1 reference

12 December 2020

10.1007/S11684-013-0272-4

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

1005045142

0 references

1 reference